Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0021-9150(97)88471-7PMID 9327766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics of the quantitative Lp(a) lipoprotein trait

  2004cited by this paper
• Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.

  1996cited by this paper
• Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.

  1996cited by this paper
• Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma.

  1996cited by this paper
• Genetic basis for multimodal relationship between apolipoprotein (a) size and lipoprotein (a) concentration in Mexican-Americans.

  1995cited by this paper
• Familial hypobetalipoproteinemia is not associated with low levels of lipoprotein(a).

  1995cited by this paper
• Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women.

  1995cited by this paper
• Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma.

  1995cited by this paper
• Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

  1995cited by this paper
• An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance.

  1995cited by this paper
• Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites.

  1995cited by this paper
• No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans.

  1995cited by this paper
• C/T polymorphism in the 5' untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation.

  1995cited by this paper
• The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.

  1995cited by this paper
• A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

  1995cited by this paper
• Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides.

  1994cited by this paper
• Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles.

  1994cited by this paper
• Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.

  1994cited by this paper
• A gene-gender interaction affecting plasma lipoproteins in a genetic isolate.

  1994cited by this paper
• DdeI polymorphism in the AGTR1 gene.

  1994cited by this paper
• A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate.

  1994cited by this paper
• Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration.

  1994cited by this paper
• Characterization of monoclonal antibodies to apolipoprotein (a) and development of a chemiluminescent assay for phenotyping apolipoprotein (a) isomorphs.

  1994cited by this paper
• MnlI polymorphism for the AGTR1 gene.

  1994cited by this paper
• Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults.

  1994cited by this paper
• Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels.

  1993cited by this paper
• Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.

  1993cited by this paper
• A prospective study of lipoprotein(a) and the risk of myocardial infarction.

  1993cited by this paper
• The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.

  1992cited by this paper
• Hedgehog lipoprotein(a) is a modulator of activation of plasminogen at the fibrin surface. An in vitro study.

  1992cited by this paper
• Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

  1992cited by this paper
• The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration

  1992cited by this paper
• Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

  1992cited by this paper
• A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals.

  1991cited by this paper
• Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.

  1991cited by this paper
• Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

  1991cited by this paper
• Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.

  1991cited by this paper
• Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.

  1990cited by this paper
• Linkage disequilibrium between DNA markers at the low‐density lipoprotein receptor gene

  1990cited by this paper
• Lipoprotein(a), fibrin binding, and plasminogen activation.

  1990cited by this paper
• The unique lipoprotein(a): properties and immunochemical measurement.

  1990cited by this paper
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

  1990cited by this paper
• Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia.

  1989cited by this paper
• Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.

  1989cited by this paper
• Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.

  1989cited by this paper
• Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

  1988cited by this paper
• Association between coagulation factors VII and X with triglyceride rich lipoproteins.

  1988cited by this paper
• Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.

  1987cited by this paper
• The general relationship between average effect and average excess.

  1987cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for myocardial infarction.

  1986cited by this paper
• A note on Fisher's 'average effect' and 'average excess'.

  1985cited by this paper
• Haemostatic function and cardiovascular death: early results of a prospective study.

  1980cited by this paper

• Circulating lipoprotein (a) and all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis

  2023cites this paper
• A Novel Mutation in the Kringle IV Domain of LPA Gene Leading to Familial Cardiovascular Diseases

  2020cites this paper
• A Novel Mutation in the Kringle IV Domain of LPA gene leading to Familial Hyperlipoproteinemia

  2019cites this paper
• Lipoprotein ( a ) ve Ateroskleroz

  2010cites this paper
• Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians

  2010cites this paper
• Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample

  2005cites this paper
• Lipoprotein(a) level and lipids in type 2 diabetic patients and their normoglycemic first-degree relatives in type 2 diabetic pedigrees.

  2003cites this paper
• The Global Epidemic of Atherosclerotic Cardiovascular Disease

  2002cites this paper
• International Conference on Coronary Heart Disease in the New Millennium Epidemiology

  2002cites this paper
• Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

  2001influential citation
• Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease.

  1999cites this paper
• Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations.

  1999cites this paper
• Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations.

  1999cites this paper
• Lipoprotein(a) as a risk factor for coronary artery disease.

  1998cites this paper
• Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.

  1998cites this paper
• Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction.

  1998cites this paper
• Genetic influence of the R/Q353 genotype on factor VII activity is overwhelmed by environmental factors in Chinese patients with Type II (non-insulin-dependent) diabetes mellitus

  1998influential citation
• Genetic polymorphisms of factor VII are not associated with arterial thrombosis

  1998cites this paper
• Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus.

  1998cites this paper
• Genetic variation in paraoxonase‐2 is associated with variation in plasma lipoproteins in Canadian Oji‐Cree

  1998cites this paper